Zobrazeno 1 - 10
of 292
pro vyhledávání: '"Charles-L. Daley"'
Autor:
James D. Chalmers, Pierre-Régis Burgel, Charles L. Daley, Anthony De Soyza, Charles S. Haworth, David Mauger, Kevin Mange, Ariel Teper, Carlos Fernandez, Dan Conroy, Mark Metersky
Publikováno v:
ERJ Open Research, Vol 10, Iss 4 (2024)
Introduction Brensocatib is an investigational, oral, reversible inhibitor of dipeptidyl peptidase-1 shown to prolong time to first exacerbation in adults with bronchiectasis. Outlined here are the clinical trial design, and baseline characteristics
Externí odkaz:
https://doaj.org/article/121e605de75c442dbf530a2bd4aafdf7
Autor:
Jane E. Gross, James D. Finklea, Silvia M. Caceres, Katie R. Poch, Nabeeh A. Hasan, Fan Jia, L. Elaine Epperson, Ettie M. Lipner, Charmie K. Vang, Jennifer R. Honda, Matthew J. Strand, Vinicius Calado Nogueira de Moura, Charles L. Daley, Michael Strong, Jerry A. Nick
Publikováno v:
ERJ Open Research, Vol 10, Iss 4 (2024)
Rationale Nontuberculous mycobacteria (NTM) has been reported to be transmitted between people with cystic fibrosis (CF) attending CF centres. A suspected Mycobacterium abscessus outbreak was investigated at the University of Texas Southwestern (UTSW
Externí odkaz:
https://doaj.org/article/4c1e359a5916408f94be2d9da8823672
Autor:
Khalid M. Dousa, Eunjeong Shin, Sebastian G. Kurz, Mark Plummer, Mary Nantongo, Christopher R. Bethel, Magdalena A. Taracila, David C. Nguyen, Barry N. Kreiswith, Charles L. Daley, Kenneth E. Remy, Steven M. Holland, Robert A. Bonomo
Publikováno v:
mBio, Vol 15, Iss 6 (2024)
ABSTRACT Mycobacterium abscessus (Mab) affects patients with immunosuppression or underlying structural lung diseases such as cystic fibrosis (CF). Additionally, Mab poses clinical challenges due to its resistance to multiple antibiotics. Herein, we
Externí odkaz:
https://doaj.org/article/fa9a808cd6454120a8ebb14d852179cd
Autor:
Andrew B. Wolf, Kelli M. Money, Arun Chandnani, Charles L. Daley, David E. Griffith, Lakshmi Chauhan, Nathan Coffman, Amanda L. Piquet, Kenneth L. Tyler, Shanta M. Zimmer, Brian T. Montague, Sarah Mann, Daniel M. Pastula
Publikováno v:
Emerging Infectious Diseases, Vol 29, Iss 8, Pp 1655-1658 (2023)
Mycobacterium abscessus infections have been reported as adverse events related to medical tourism. We report M. abscessus meningitis in a patient who traveled from Colorado, USA, to Mexico to receive intrathecal stem cell injections as treatment for
Externí odkaz:
https://doaj.org/article/b15fdced5e354e61aaa1c836cafb04d7
Autor:
Nabeeh A. Hasan, Rebecca M. Davidson, L. Elaine Epperson, Sara M. Kammlade, Sean Beagle, Adrah R. Levin, Vinicius Calado de Moura, Joshua J. Hunkins, Natalia Weakly, Scott D. Sagel, Stacey L. Martiniano, Max Salfinger, Charles L. Daley, Jerry A. Nick, Michael Strong
Publikováno v:
Emerging Infectious Diseases, Vol 27, Iss 11, Pp 2836-2846 (2021)
Mycobacterium avium complex (MAC) species constitute most mycobacteria infections in persons with cystic fibrosis (CF) in the United States, but little is known about their genomic diversity or transmission. During 2016–2020, we performed whole-gen
Externí odkaz:
https://doaj.org/article/6a40def187f344059fc57d2a76590a8d
Autor:
Rebecca M. Davidson, Jeanne B. Benoit, Sara M. Kammlade, Nabeeh A. Hasan, L. Elaine Epperson, Terry Smith, Sruthi Vasireddy, Barbara A. Brown-Elliott, Jerry A. Nick, Kenneth N. Olivier, Adrian M. Zelazny, Charles L. Daley, Michael Strong, Richard J. Wallace
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Recent studies have characterized a dominant clone (Clone 1) of Mycobacterium abscessus subspecies massiliense (M. massiliense) associated with high prevalence in cystic fibrosis (CF) patients, pulmonary outbreaks in the United States (US) a
Externí odkaz:
https://doaj.org/article/65f02a743ac340e2baeb45d175365d25
Autor:
Emily Henkle, Charles L. Daley, Jeffrey R. Curtis, Benjamin Chan, Timothy R. Aksamit, Kevin L. Winthrop
Publikováno v:
ERJ Open Research, Vol 8, Iss 1 (2022)
Introduction Bronchiectasis is an increasingly common chronic inflammatory airway disease. We evaluated secondary safety outcomes in a comparative effectiveness study of chronic inhaled corticosteroids (ICS) and macrolide monotherapy in bronchiectasi
Externí odkaz:
https://doaj.org/article/47c202c6496e4a7fb5463bd580cd6111
Autor:
Khalid M. Dousa, David C. Nguyen, Sebastian G. Kurz, Magdalena A. Taracila, Christopher R. Bethel, William Schinabeck, Barry N. Kreiswirth, Sheldon T. Brown, W. Henry Boom, Richard S. Hotchkiss, Kenneth E. Remy, Frank J. Jacono, Charles L. Daley, Steven M. Holland, Alita A. Miller, Robert A. Bonomo
Publikováno v:
mBio, Vol 13, Iss 1 (2022)
ABSTRACT Mycobacterium abscessus (Mab) infections are a growing menace to the health of many patients, especially those suffering from structural lung disease and cystic fibrosis. With multidrug resistance a common feature and a growing understanding
Externí odkaz:
https://doaj.org/article/89354fdd37e14eba94df814fcd3ea960
Publikováno v:
European Respiratory Review, Vol 31, Iss 163 (2022)
Nontuberculous mycobacterial pulmonary disease (NTM-PD) remains a challenging condition to diagnose and treat effectively. Treatment of NTM-PD is prolonged, frequently associated with adverse effects and has variable success. In this review, we consi
Externí odkaz:
https://doaj.org/article/122af0c2ad194141bd3fe14bc292097a
Autor:
Noah Goldstein, J. Benjamin St. Clair, Shannon H. Kasperbauer, Charles L. Daley, Bennie Lindeque
Publikováno v:
Emerging Infectious Diseases, Vol 25, Iss 6, Pp 1075-1083 (2019)
Nontuberculous mycobacteria represent an uncommon but important cause of infection of the musculoskeletal system. Such infections require aggressive medical and surgical treatment, and cases are often complicated by delayed diagnosis. We retrospectiv
Externí odkaz:
https://doaj.org/article/36e626899e1a4c929f3c3ff52a4903a6